ArticleMedicine2026
Trends in incidence, prevalence, and mortality of peptic ulcer disease in Asia (1990-2023) and projections to 2040.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study provides the first comprehensive assessment of the burden of peptic ulcer disease (PUD) in Asia, analyzing epidemiological trends from 1990 to 2023 with projections to 2040.
methodsUsing data from the Global Burden of Disease Study 2023, we analyzed PUD metrics across 48 Asian countries and territories. Age-standardized rates were calculated by the direct method. Temporal trends were evaluated by Joinpoint regression, and future burden was projected to 2040 using autoregressive integrated moving average (ARIMA) modeling.
resultsIn 2023, Asia recorded 1.87 million incident PUD cases (age-standardized incidence rate: 39.34 per 100,000), 4.32 million prevalent cases (age-standardized prevalence rate: 90.58 per 100,000), and 131,011 deaths (age-standardized death rate: 2.85 per 100,000). PUD caused 3.46 million Disability-adjusted life years, with premature mortality accounting for >90% of the total burden. From 1990 to 2023, Joinpoint regression revealed significant declining trends across all age-standardized metrics (annual percentage change range: -1.32%-- 3.27%; all P < .05). ARIMA projections to 2040 suggest continued decreases in all rates, with years lived with disability expected to exceed years of life losts as the dominant component of disease burden.
conclusionDespite declining incidence, PUD continues to impose a substantial disease burden across Asia. The persistent toll: driven by an expanding and aging population: underscores the need for sustained prevention efforts, including population-based Helicobacter pylori screening, rational non-steroidal anti-inflammatory drugs prescribing, and health system capacity for emergency endoscopic intervention and long-term chronic disease management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.